Expert Pitch
Virginia Tech

Telemedicine is changing the way healthcare will be done in the future

9-Apr-2020 8:45 AM EDT, by Virginia Tech

Telemedicine is changing the way providers connect with patients to maintain social distancing and decrease high risk patients from having to travel to a medical office.

The COVID-19 pandemic opens the door for an increase in virtual care and could be a cost saving to healthcare systems in the future, says Dr. Stephen Morgan, senior vice president and chief medical information officer at the Carilion Clinic and a faculty member at the Virginia Tech Carilion School of Medicine.

Quoting Morgan

“Almost every hospital system in the country is developing a virtual care program. It offers a virtual care suite of solutions to assist providers and evaluate patients remotely.”

“Virtual care can be done both in an ambulatory and inpatient setting. One key element for hospital systems is to develop the use case for virtual care and ensure that there is support both from the providers and the community for this type of care delivery. Telemedicine is a tool in our tool kit for clinicians to provide patient care. It does not replace face to face visits when needed.”

Morgan says that we still have a lot to learn about virtual care, and in what settings it should be delivered. “It is not a panacea and must be used like any other tool for patient care. Not all care can be managed virtually however we are finding more options that are both convenient for the patient and provide equal quality to a face-to-face visit.”

“There are however still times that it is more effective for a face-to-face visit in particular for chronic care management. There is also a component of how comfortable the patient feels with a virtual interaction, which needs to be considered as medical providers continue to develop virtual care programs.”

Morgan says there has been a lot of support for virtual care, but the federal and state sponsored insurance plans like Medicare and Medicaid have been slower to cover virtual care. “Over the last year both Medicare and Medicaid have started to increase their coverage for the services since the data has shown it is a more affordable option to provide virtual patient care in specific settings.”

About Morgan

Dr. Morgan oversees clinical informatics, and data analytics for the Carilion Clinic health system. He also co-leads Carilion’s digital health program. A board-certified physician in family medicine, Dr. Morgan still sees patients and is an assistant professor at the Virginia Tech Carilion School of Medicine.

Our studio

Finding reliable experts for media interviews is especially important during this difficult time. Virginia Tech's television and radio studios can broadcast live HD audio and video to networks, news outlets, and affiliates interviewing Virginia Tech faculty and staff. The university does not charge for use of its studios. Video is transmitted by LTN Global Communications; Skype, FaceTime, or similar products; or file sharing (Dropbox, Google Drive, We-Transfer, etc.). Radio interviews can be transmitted by ISDN, Comrex, phone, smartphone recording, or file sharing.  




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.596